3-8 September 2016 Dubai
23-P | COST-BENEFIT ANALYSIS AND VALIDATION OF THE RFID-BASED TRACEABILITY SYSTEM DEPLOYED IN SEVILLE-HUELVAS BLOOD ESTABLISHMENT | Aida Agea | Received |
28-P | ECONOMIC MODELLING FOR TRANSFUSION MEDICINE IMPROVEMENT INITIATIVES IN NSW, AUSTRALIA | Sally Francis | Received |
37-P | GLOBAL RISK MANAGEMENT SYSTEM : A PART OF MANAGEMENT AND DECISION MAKING | WIDED SGHAIER | Received |
59-P | IMPROVEMENT OF QUALITY INDICATORS FOLLOWING IMPLEMENTATION OF REAL-TIME AUTOMATED RED BLOOD CELL ORDERING ALGORITHM BASED ON RETROSPECTIVE AND PROSPECTIVE HOSPITAL DATA | JGQ Quinn | Received |
138-P | THE EFFECT OF A SINGLE WHOLE BLOOD DONATION ON COMPLETE BLOOD COUNT VALUES AND LYMPHOCYTE SUBSETS | Mohammed Almohammadi | Received |
143-P | SIGNS AND SYMPTOMS OF VASOVAGAL DONOR ADVERSE REACTIONS | Hany Kamel | Received |
150-P | VEIN SUITABILITY SCORING TO PREDICT PHLEBOTOMY OUTCOMES IN YOUNG WHOLE BLOOD DONORS | Phillip Mondy | Received |
160-P | PROVIDING OF IMMUNOLOGICAL AND INFECTION PLATELET SAFETY BY CRYOPRESERVATION | IV Vysochin | Received |
190-P | ARE THE CELL SEPARATORS SPECTRA OPTIA AND AMICUS EQUALLY SUITABLE FOR COLLECTION OF MNCS AND THEIR SUBSETS | Gerda Leitner | Received |
212-P | IN VITRO EVALUATION OF WHOLE BLOOD-DERIVED THERAFLEX MB-PLASMA FOR REGISTRATION IN FRANCE | Beatrice BELCOUR | Received |
213-P | EVALUATION OF WHOLE BLOOD-DERIVED PLASMA QUALITY TREATED WITH THE THERAFLEX PATHOGEN INACTIVATION SYSTEM FOR REGISTRATION IN FRANCE | Stephane BEGUE | Received |
214-P | THROMBIN GENERATION TEST OF POOLED WHOLE BLOOD DERIVED PLASMA AFTER PHOTOCHEMICAL TREATMENT AND STORAGE | Catherine RAVANAT | Received |
240-P | SEROPREVELANCE OF HEPATITIS E VIRUS (HEV) IN THE SWISS BLOOD DONORS: BASIS FOR FUTURE STRATEGY FOR PREVENTING HEV TRANSMISSION TO AT RISK INDIVIDUALS | Christoph Niederhauser | Received |
265-P | SIXTEEN MONTH EXPERIENCE WITH THE COBAS MPX TEST ON THE COBAS 8800 SYSTEM IN A ROUTINE SCREENING SETTING | Martin Stolz | Received |
283-P | PERFORMANCE OF A NEW AUTOMATED ASSAYS FOR HEPATITIS B SURFACE ANTIGEN AND HEPATITIS B CORE | George Schlauder | Received |
285-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTIBODIES TO HEPATITIS C | George Schlauder | Received |
294-P | PATTERNS IN HIV INCIDENCE IN REPEAT AND FIRST-TIME AND DONORS IN BRAZIL | Brian Custer | Received |
295-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR HIV | George Schlauder | Received |
303-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR SYPHILIS | George Schlauder | Received |
305-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR ANTIBODIES TO T. CRUZI | George Schlauder | Received |
315-P | PERFORMANCE OF A NEW AUTOMATED ASSAY FOR HTLV I/II | George Schlauder | Received |
319-P | COMPARISON OF THREE AUTOMATED BLOOD TYPING SYSTEMS FOR ABO/D TYPING IN ABO SUBGROUP | Bo Kyeung Jung | Received |
330-P | DIRECT BLOOD GROUP TYPING USING MDMULTICARD LATERAL FLOW TECHNIQUE WITH ANTIBODIES FROM POLYCLONAL SOURCE | Matteo Binda | Received |
349-P | COMPARISON OF SENSITIVITY AND SPECIFICITY OF THE BIO-RAD ID CARDS LISS/COOMBS WITH THE GRIFOLS GEL COOMBS CARDS IN A MANUAL APPROACH | Hein Hustinx | Received |
365-P | NECESSITY OF TUBE METHOD IN RBC ANTIBODY SCREEN: PERSPECTIVE FROM A CASE OF COLD AGGLUTININ DISEASE | Yanhua Li | Received |
375-P | PERFORMANCE CHARACTERISTICS OF A NOVEL ANTI-MIA MONOCLONAL ANTIBODY-BASED REAGENT IN A CANADIAN POPULATION | John Saldanha | Received |
377-P | A PATIENT OF CAUCASIAN ORIGIN WITH ANTI-SC3 AND THE SC-NULL PHENOTYPE DUE TO A NOVEL ERMAP MUTATION | Christine Henny | Received |
403-P | FREQUENCY OF ABO, RHESUS PHENOTYPES AND MOST PROBABLE GENOTYPES AND THE TYPE OF RHD NEGATIVE VARIANTS AMONG UAE NATIONALS IN AL AIN DISTRICT | Mariam Al Meqbali | Received |
458-P | THERAPEUTIC PLASMA EXCHANGE: A TERTIARY CARE CENTER EXPERIENCE | Maha Badawi | Received |
459-P | THERAPEUTIC PLASMA EXCHANGE WITH 5 ALBUMIN REPLACEMENT IN A PATIENT WITH CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME ON FONDAPARINUX | Yanhua Li | Received |
484-P | MEASUREMENT FOR STRATEGIC IMPROVEMENT AND CLINICIAN FEEDBACK: PATIENT BLOOD MANAGEMENT IN NEW SOUTH WALES, AUSTRALIA | Sally Francis | Received |
492-P | PLATELET TRANSFUSION EFFECTIVENESS | Eugene Zhiburt | Received |
499-P | RETROSPECTIVE ANALYSIS OF TRANSFUSION REACTION REPORTING AT A TERTIARY HOSPITAL IN ABUDHABI | Fatmah AlMazam | Received |
501-P | MECHANISMS UNDERPINNING TRANSFUSION RELATED IMMUNE MODULATION: ERYTHROPHAGOCYTOSIS AND IMMUNE MODULATION IN DIFFERENT MYELOID CELL SUBSETS | Melinda Dean | Received |
505-P | HYPERHEMOLYSIS SYNDROME IN A SICKLE CELL DISEASE/THALASSEMIA PATIENT: THE ROLE OF IMMUNOTHERAPY | Fatima Alkaabi | Received |
532-P | POTENTIAL USE OF THE ISBT 128 PRODUCT DESCRIPTION CODE DATABASE FOR HAEMOVIGILANCE REPORTING AND ANALYSIS | Monica Freire | Received |
533-P | HOW TECHNOLOGY CONTRIBUTES TO REDUCE ERRORS IN TRANSFUSION PROCEDURES OF A TERTIARY-CARE HOSPITAL | Nelly Carpio Martinez | Received |
561-P | RED BLOOD CELL TRANSFUSION IN TOTAL HIP AND KNEE REPLACEMENT | Natalya Grechanyuk | Received |
598-P | DOES PATIENT HLA TYPE PREDICT THE RISK OF RED BLOOD CELL ALLOIMMUNIZATION? | Ghada Mawad | Received |
3-8 September 2016 Dubai
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|